Latest filing published 02 Mar 2016 for Oncternal Therapeutics, Inc., €24k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
J. Kenneth Glass: trading record in brief
J. Kenneth Glass has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Oncternal Therapeutics, Inc. and First Horizon Corp. Between 1 January 2006 and 1 March 2016, the trades on record add up to 69 filings.
Both buying and selling appear: 19 purchases worth €416k, against 1 sale worth €1.7M. Sales outweigh purchases by €1.2M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 46 share grants and 1 option exercise. Since January 2016: 1 purchase and no sales on the market.
Half of the purchases are above €21k and half below.
Most recently, on 2 March 2016, the filings show an open-market purchase worth €24k in Oncternal Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to J. Kenneth Glass
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 44,000 shares@ US$0.60100.0% of flowCommon StockSEC:0001179110-16-020661:0Canonical exit: 30 May 2016 (T+90)
- 100 shares@ US$0.79Common StockSEC:0001179110-15-016749:0Canonical exit: 23 Mar 2016 (T+90)
- 600 shares@ US$0.79Common StockSEC:0001179110-15-016690:0Canonical exit: 22 Mar 2016 (T+90)
- 1,307 shares@ US$0.78Common StockSEC:0001179110-15-016690:1Canonical exit: 21 Mar 2016 (T+90)
- 39,900 shares@ US$0.78Common StockSEC:0001179110-15-016620:0Canonical exit: 20 Mar 2016 (T+90)
- 24,500 shares@ US$1.25Common StockSEC:0001179110-15-008153:0Canonical exit: 17 Aug 2015 (T+90)
- 10,000 shares@ US$0.72Common StockSEC:0001179110-15-006513:0Canonical exit: 21 Jul 2015 (T+90)
- 3,952 shares@ US$0.72Common StockSEC:0001179110-15-006491:0Canonical exit: 19 Jul 2015 (T+90)
- 7,656 shares@ US$0.71Common StockSEC:0001179110-15-006491:1Canonical exit: 20 Jul 2015 (T+90)
- 3,300 shares@ US$0.72Common StockSEC:0001179110-15-006332:0Canonical exit: 14 Jul 2015 (T+90)
- 16,400 shares@ US$0.67Common StockSEC:0001179110-15-006265:0Canonical exit: 9 Jul 2015 (T+90)
- 10,000 shares@ US$3.76Common StockSEC:0001209191-12-043386:0Canonical exit: 25 Nov 2012 (T+90)
- 16,050 shares@ US$6.27Common StockSEC:0001209191-11-033694:0Canonical exit: 4 Sept 2011 (T+90)
- 15,000 shares@ US$3.83Common StockSEC:0001209191-11-023688:0Canonical exit: 14 Jul 2011 (T+90)
- 7,500 shares@ US$2.70Common StockSEC:0001209191-10-035526:0Canonical exit: 20 Sept 2010 (T+90)
- 5,000 shares@ US$10.27Common StockSEC:0001209191-09-009604:0Canonical exit: 13 May 2009 (T+90)
- 5,000 shares@ US$10.65Common StockSEC:0001209191-09-005257:0Canonical exit: 28 Apr 2009 (T+90)
- 209.06 shares@ US$14.35Common StockSEC:0001209191-08-000405:0
- 1,000 shares@ US$18.41Common StockSEC:0001209191-07-030582:0
- 200 shares@ US$18.37Common StockSEC:0001209191-07-030582:1
- 100 shares@ US$18.36Common StockSEC:0001209191-07-030582:2
- 300 shares@ US$18.35Common StockSEC:0001209191-07-030582:3
- 800 shares@ US$18.34Common StockSEC:0001209191-07-030582:4
- 173 shares@ US$18.32Common StockSEC:0001209191-07-030582:5
- 200 shares@ US$18.31Common StockSEC:0001209191-07-030582:6
25 of 62 declarations
